SCHEMBL28364566

SCHEMBL28364566

CON(C)C(=O)c1cnc(C2=CCN(C(=O)O)CC2)nc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ QDPR P09417 1/20 0.34
▸ GRM5 P41594 1/20 0.34
▸ GRM1 Q13255 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ GPR119 Q8TDV5 2/20 0.33
▸ CCNT1 O60563 1/20 0.33
▸ CDK9 P50750 1/20 0.33
▸ ADAM10 O14672 1/20 0.33
▸ ERBB2 P04626 1/20 0.33
▸ MMP2 P08253 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ HRH3 Q9Y5N1 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20759707 0.85 GRM1 (0.48) GRM5GRM1GPR119NAMPT
SCHEMBL28884398 0.77 RXFP1 (0.45) ALDH1A1GRM5TDP1MEN1KMT2A
SCHEMBL18009528 0.77 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2QDPRGRM5GRM1
SCHEMBL10317879 0.75 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2KCNH2HRH3GAA
SCHEMBL25185933 0.74 GPR119 (0.43) ALDH1A1GPR119MEN1KMT2ATSHR
SCHEMBL28966541 0.74 TRPV1 (0.45) ALDH1A1SMN1; SMN2TRPV1
SCHEMBL20759869 0.73 QDPR (0.36) QDPRCCNT1CDK9KCNH2HRH3
SCHEMBL28368651 0.72 NPC1 (0.44) ALDH1A1SMN1; SMN2GRM5GRM1GAA
SCHEMBL2100256 0.72 NAMPT (0.36) ALDH1A1SMN1; SMN2GRM5GRM1CCNT1
SCHEMBL15952943 0.72 NAMPT (0.47) TDP1KMT2ANPC1RAB9ANAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111410648-B Chiral c-KIT inhibitor drug key intermediate and preparation method thereof 浙江海正药业股份有限公司 2024-03-29 — — CN disclosed
CN-117098760-A Compositions and methods for treating KIT and PDGFRA mediated diseases 缆图药品公司 2023-11-21 — — CN disclosed
CN-110891953-B Pyrrolotriazines derivatives, preparation method and application thereof 浙江海正药业股份有限公司 2022-07-12 — — CN disclosed
CN-111410648-A Chiral c-KIT inhibitor drug key intermediate and preparation method thereof 浙江海正药业股份有限公司 2020-07-14 — — CN disclosed
CN-110891953-A Pyrrolotriazines derivatives, preparation method and application thereof 浙江海正药业股份有限公司 2020-03-17 — — CN disclosed
Send feedback